Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $4.1 million.

  • KORU Medical Systems' Cost of Revenue rose 3819.68% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 2377.15%. This contributed to the annual value of $12.3 million for FY2024, which is 427.81% up from last year.
  • KORU Medical Systems' Cost of Revenue amounted to $4.1 million in Q3 2025, which was up 3819.68% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Cost of Revenue registered a high of $4.1 million during Q3 2025, and its lowest value of $2.2 million during Q1 2021.
  • Over the past 5 years, KORU Medical Systems' median Cost of Revenue value was $3.0 million (recorded in 2023), while the average stood at $3.0 million.
  • As far as peak fluctuations go, KORU Medical Systems' Cost of Revenue soared by 5106.8% in 2021, and later tumbled by 2260.05% in 2023.
  • Quarter analysis of 5 years shows KORU Medical Systems' Cost of Revenue stood at $2.7 million in 2021, then grew by 22.86% to $3.3 million in 2022, then dropped by 12.6% to $2.9 million in 2023, then grew by 14.74% to $3.3 million in 2024, then grew by 26.31% to $4.1 million in 2025.
  • Its Cost of Revenue stands at $4.1 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.6 million for Q1 2025.